PDI Inc (PDII) Mega-Deal In Focus; MSCI Inc (MSCI) Upward Rating Momentum

PDI_PDII

PDI, Inc. (Nasdaq:PDII) said that it will receive between $25.5 million to $32.5 million as an initial cash payment at closing from the sale of its Commercial Services business to Publicis Healthcare Communications Group, part of Publicis Groupe.

PDII shares finished Friday’s trading session at $1.63, down $0.07 (or -4.12%)

PDI, Inc., a leading healthcare commercialization company, has 16.72M Shares Outstanding, Market Capitalization (intraday) of $27.25M and PDII stock 52-week range is $1.00 – $2.74 per share.

*

MSCI

Brokerage firm Keefe Bruyette upgraded MSCI Inc. (NYSE:MSCI) shares from an Underperform to a Market Perform rating and raised its price target from $59.00 to $66.00.

MSCI recently reported third quarter 2015 operating revenues of $268.8 million, a 6.8% increase year over year, and adjusted (excluding non-recurring items) net income of $65.73 million, or $0.60 per diluted share, compared to adjusted net income of $59.21 million, or $0.50 per diluted share in the same period the prior year

Shares of MSCI surged $1.48 (or +2.26%) to $67.00 on Friday’s market activity

MSCI, which provides investment decision support tools worldwide, has 109.66M Shares Outstanding, Market Capitalization (intraday) of $7.35B and MSCI stock one-year range is between $45.66 and $68.83 per share.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/